Showing 251-260 of 840 results for "".
Drug Companies, Insurance Companies, Pharmacists, the Government, Doctors and…Oh, Patients!
https://practicaldermatology.com/topics/practice-management/drug-companies-insurance-companies-pharmacists-the-government-doctors-andoh-patients/21063/Teledermatology Update: Restrictions Lifted Due to COVID-19
https://practicaldermatology.com/topics/practice-management/teledermatology-update-restrictions-lifted-due-to-covid-19/23256/Easing of guidelines may allow more practices to add teleconsults.Viewpoints: When is it Enough?
https://practicaldermatology.com/topics/general-topics/viewpoints-when-is-it-enough/21104/As MOC concerns mount, one specialist is calling for a poll of dermatologists.Education is Key to Preventing Skin Cancers
https://practicaldermatology.com/topics/skin-cancer-photoprotection/education-is-key-to-preventing-skin-cancers/22938/Resolution of Primary Erythromelalgia Following Ibuprofen; Fire Power
https://practicaldermatology.com/youngmd-connect/resident-resource-center/resolution-of-primary-erythromelalgia-following-ibuprofen-fire-power/20619/Stirring the Pot: Cannabinoids and Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/stirring-the-pot-cannabinoids-and-atopic-dermatitis/20565/Cannabinoids are a diverse group of compounds that may hold significant therapeutic capabilities applicable to many areas of medicine, including dermatology.CBD in the Holistic Practice of Dermatology
https://practicaldermatology.com/topics/psoriasis/cbd-in-the-holistic-practice-of-dermatology/23319/A growing body evidence suggests CBD may help with common symptoms of dermatologic diseases. Here’s what we know so far.Diagnosing and Managing Hair Disorders
https://practicaldermatology.com/topics/general-topics/diagnosing-and-managing-hair-disorders/20624/From loss to overgrowth, hair disorders may be associated with systemic causes.Cutaneous T-Cell Lymphoma: Mogamulizumab as a Novel Treatment for Refractory Mycosis Fungoides and Sezary Syndrome
https://practicaldermatology.com/youngmd-connect/resident-resource-center/Cutaneous-T-Cell-Lymphoma-Mogamulizumab-as-a-Novel-Treatment-for-Refractory-Mycosis-Fungoides-and-Sezary-Syndrome/23409/An overview of the diagnosis and prognosis of CTCL.Dupilumab For the Management of Pembrolizumab-induced Rash: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/dupilumab-for-the-management-of-pembrolizumab-induced-rash-a-case-report/23841/